Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-29

Clinical Trial Update: Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 bridge study to evaluate the efficacy and safety of IN-B00009 injections in adults with Type 2 diabetes not adequ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IN-B00009 (IN-B00009)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Diabetes (DM), Diabetes Mellitus Type 2 | Phase 3 | Status: NOT_YET_RECRUITING